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Expression of the herpes simplex virus type 1 (HSV-1) glycoproteins gB, gD, gH, and gL is necessary and sufficient to cause cell fusion.
To identify the requirements for a membrane-spanning domain in HSV-1 glycoprotein-induced cell fusion, we created gB, gD, and gH
mutants with transmembrane and cytoplasmic domains replaced by a glycosylphosphatidylinositol (gpi)-addition sequence. The
corresponding gBgpi, gDgpi, and gHgpi proteins were expressed with wild-type efficiency at the cell surface and were linked to the
plasma membrane via a gpi anchor. The gDgpi mutant promoted cell fusion near wild-type gD levels when co-expressed with gB, gH, and gL
in a cell-mixing fusion assay, indicating that the gD transmembrane and cytoplasmic domains were not required for fusion activity. A plasma
membrane link was required for fusion because a gD mutant lacking a transmembrane and cytoplasmic domain was nonfunctional for fusion.
The gDgpi mutant was also able to cooperate with wild-type gB, gH, and gL to form syncytia, albeit at a size smaller than those formed in the
wild-type situation. The gBgpi and gHgpi mutants were unable to promote fusion when expressed with the other wild-type viral
glycoproteins, highlighting the requirement of the specific transmembrane and cytoplasmic domains for gB and gH function.
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phospholipase CIntroduction
Virus-to-cell and cell-to-cell fusion induced by herpes
simplex virus (HSV) require four envelope glycoproteins
(gB, gD, gH, and gL) (Balan et al., 1994; Cai et al., 1988a,
1988b; Davis-Poynter et al., 1994; Forrester et al., 1992;
Highlander et al., 1988; Huff et al., 1988; Hutchinson et al.,
1992; Johnson and Ligas, 1988; Johnson et al., 1988; Ligas
and Johnson, 1988; Roop et al., 1993; Wilson et al., 1994).
Herpes simplex virus type 1 (HSV-1)-induced cell fusion
can result in the formation of giant multinucleated cells,
called syncytia, which are created by the fusion of infected
cells with adjacent uninfected cells. Syncytia are observed
in HSV-induced lesions and may represent a mechanism of
cell killing during infection (Pertel and Spear, 1998; Spear,0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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absence of infectious virus by the expression of gB, gD, gH,
and gL in cells that express a gD receptor (Klupp et al.,
2000; Muggeridge, 2000; Pertel et al., 2001; Turner et al.,
1998).
Cell fusion can also be detected by mixing cells express-
ing gB, gD, gH, and gL with cells expressing a gD receptor
(Pertel et al., 2001). Expression of all four viral envelope
glycoproteins is required for fusion to occur (Browne et al.,
2001; Muggeridge, 2000; Pertel et al., 2001; Turner et al.,
1998). The only cellular factor thus far identified to be
required for fusion induced by HSV-1 envelope glycopro-
teins is a gD receptor (Pertel et al., 2001). Cell-surface
glycosaminoglycans are not required for fusion (Browne et
al., 2001; Pertel et al., 2001), despite the ability of gB to
bind them (Herold et al., 1991, 1994). The binding of gD to
receptor is critical for fusion and may initiate the fusion
process. The details of what happens after gD binds receptor
are poorly understood. Presumably, gD, gB, gH, and gL
bind other cell-surface factors or interact with the apposing
membrane to achieve fusion.
Fig. 1. Wild-type HSV-1 envelope glycoproteins and gpi-linked mutants.
Areas shaded in gray represent predicted hydrophobic domains, some of
which are transmembrane domains. Numbers above the individual
glycoprotein indicate the amino acid number where domain begins.
Numbers below glycoprotein indicate amino acid number where domain
ends. The numbers, ‘‘1, 2, 3’’ represent the first, second, and third predicted
hydrophobic domains of gB. Black box represents sequence added from
DAF (the final 37 amino acids) that signals the addition of a gpi anchor.
Number before black box indicates amino acid of glycoprotein fused to
DAF sequence. Amino acid numbers include the signal sequence and
correspond to the sequence in GenBank accession numbers E03113 (gB),
L09243 (gD), X03896 (gH), and M31516 (DAF). Drawing is not to scale.
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and cytoplasmic tail differ among the HSV-1 envelope
glycoproteins. The specific transmembrane and cytoplasmic
domains of gH are required for gH to function in fusion
(Harman et al., 2002). Mutations in the cytoplasmic tail of
gB can abolish or enhance fusion depending upon their
location, whereas mutations in the cytoplasmic tail of gH
can abolish fusion (Baghian and Kousoulas, 1993; Baghian
et al., 1993; Cavalcoli et al., 1993; Diakidi-Kosta et al.,
2003; Fan et al., 2002; Foster et al., 2001; Wilson et al.,
1994). In contrast, gD can function when its cytoplasmic tail
is deleted or its transmembrane domain and cytoplasmic tail
are replaced by those from other transmembrane proteins
(Cairns et al., 2003; Feenstra et al., 1990; Whiteley et al.,
1999).
Many viruses encode a single protein capable of
performing fusion. Some of these fusion proteins, called
class I or type I fusion proteins, have many common
characteristics (Colman and Lawrence, 2003). Examples
of type I fusion proteins are influenza hemagglutinin
(HA), human immunodeficiency virus gp160, and para-
myxovirus F. None of the required four HSV-1 envelope
glycoproteins has yet been found to possess all the charac-
teristics of a type I fusion protein. However, because it
appears that general aspects of fusion are conserved among
most viruses, the characteristics of type I fusion proteins
responsible for mediating fusion may be distributed among
the four HSV envelope glycoproteins.
Type I fusion proteins with their transmembrane and
cytoplasmic domains replaced by a glycosylphosphatidyli-
nositol (gpi) linkage are nonfunctional for fusion (Kemble et
al., 1994; Markosyan et al., 2000; Tong and Compans,
2000; Weiss and White, 1993; Zhou et al., 1997). In cell
fusion assays, the influenza HA-gpi mediates the fusion of
the outer leaflet of lipid membranes but without complete
lipid bilayer fusion or mixture of cytoplasmic contents
(Kemble et al., 1994; Melikyan et al., 1997; Markosyan et
al., 2000). This partial and incomplete fusion is called
hemifusion (Kemble et al., 1994). HA-gpi may actually
form small fusion pores that do not enlarge sufficiently to
allow fusion, suggesting that a membrane-spanning domain
is required for the enlargement of fusion pores (Markosyan
et al., 2000). Recently, a gpi-linked form of HSV-1 gD was
unable to mediate cell fusion when expressed with wild-type
gB, gH, and gL (Browne et al., 2003). The gDgpi mutant
mediated virus-to-cell fusion because it complemented the
entry defect of a gD minus isolate of HSV-1, albeit the
gDgpi-containing virions entered cells at a rate slower than
virions with wild-type gD (Browne et al., 2003). Although
HSV-1 gD does not display many characteristics of a type I
fusion protein, these results suggest that a membrane-span-
ning domain is required for gD to function in cell fusion and
that gD may have a greater role in fusion than receptor
binding.
Because investigations of gpi-linked type I fusion pro-
teins indicate that a membrane-spanning domain may benecessary for the leverage or force required to form or
enlarge fusion pores, we were interested in determining if
membrane-spanning domains were required for fusion in the
HSV-1 four glycoprotein fusion system. We removed the
transmembrane domains and cytoplasmic tails from gB, gD,
and gH and replaced them with the gpi-addition sequence
from decay-accelerating factor (DAF). If a gpi-linked ver-
sion of gD, gB, or gH was functional for fusion, then that
particular glycoprotein is unlikely to be directly involved in
the formation and enlargement of fusion pores in a manner
analogous to a type I fusion protein. We show here that
gDgpi, gBgpi, and gHgpi were expressed efficiently at the
cell surface and were linked to the plasma membrane via a
gpi anchor. Only gDgpi promoted fusion when co-expressed
with the other wild-type proteins. The fusion activity of
gDgpi was near wild-type gD levels in a cell-mixing fusion
assay. However, the gDgpi mutant, although capable of
inducing syncytium formation when expressed with gB,
gH, and gL, formed smaller syncytia over time when
compared to the wild-type situation.Results
Plasmids expressing gpi-linked versions of gD, gB, and gH
To determine if a membrane-spanning domain and cyto-
plasmic tail were required for HSV-1 glycoprotein function,
gpi-linked versions of the fusion glycoproteins were created.
Proteins linked to the plasma membrane via a gpi anchor do
not span the membrane but are tethered to the outer leaflet
of the lipid bilayer. Fig. 1 is a diagram of versions of gB,
gD, and gH with their transmembrane domains and cyto-
plasmic tails replaced by a gpi-addition sequence from
decay-accelerating factor (DAF). The gDgpi mutant con-
tains the entire predicted extracellular domain of gD fused to
the gpi-addition sequence from DAF. It was suggested that
gB may span the membrane three times because of the
length of hydrophobic domains 1, 2, and 3 (Pellett et al.,
Fig. 2. Cell-surface expression and PIPLC sensitivity of gpi-linked
glycoproteins using CELISA analysis. The envelope glycoprotein-express-
ing cells were treated with PIPLC or mock treated, incubated with a
glycoprotein-specific antibody, followed by an antibody detection system.
Mean results and standard deviations for a representative set of experiments
are listed. Each experiment was performed a minimum of three times. The
absence of error bars for mean values given is due to standard deviations
too small to generate visible error bars. (A) CHO-K1 cells were transfected
with plasmids expressing gD, gDgpi, and a control plasmid. Cell-surface
expression of gD and gDgpi was detected using anti-gD serum R7. (B)
CHO-K1 cells were transfected with plasmids expressing gH and gL, gH
and control plasmid, gHgpi and gL, gHgpi and control plasmid, or control
plasmid. The anti-gH antibody 52S-43 was used to detect cell-surface
expression of gH and gHgpi. (C) CHO-K1 cells were transfected with
plasmids expressing gB, gBgpi, or control plasmid. The anti-gB serum R74
was used to detect cell-surface expression of gB and gBgpi.
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gBgpi just before hydrophobic domain 1 to ensure that
gBgpi did not span the membrane. The gHgpi mutant
contains the entire predicted extracellular domain fused to
the DAF gpi-addition sequence. Because gL does not
contain a membrane-spanning domain, no gpi-linked ver-
sion was created.
Cell-surface expression and PIPLC cleavage of gpi-linked
mutants
Phosphatidylinositol phospholipase C (PIPLC) cleaves
gpi anchors and releases gpi-anchored proteins from the cell
surface. As an indication of whether the predicted gpi-
anchored versions of gB, gD, and gH were actually linked
to the plasma membrane via a gpi anchor, Chinese hamster
ovary K1 (CHO-K1) cells expressing the proteins were
treated with PIPLC before CELISA or flow cytometry
analysis. Both assays measure expression of cell-surface
protein. The CELISA assay involved incubating live cells
with PIPLC followed by primary anti-glycoprotein anti-
body, fixing the cells, and adding biotinylated secondary
antibody, and a streptavidin-conjugated horseradish perox-
idase. After the addition of substrate, horseradish peroxidase
activity was measured as an indication of cell-surface
protein expression (see Materials and Methods). CHO-K1
cells were transfected with plasmids expressing the wild-
type or gpi-linked versions of the three envelope glycopro-
teins. The results in Fig. 2A demonstrate that the gDgpi
mutant was expressed efficiently at the cell surface and that
a significant fraction of the gDgpi was removed from the
cell surface by PIPLC treatment although wild-type gD was
unaffected. The gHgpi mutant was expressed efficiently at
the cell surface when gL was co-expressed and gHgpi was
sensitive to cleavage by PIPLC although wild-type gH was
not (Fig. 2B). In the absence of gL, there was a small but
reproducible increase in cell-surface expression of gHgpi
over wild-type gH that was also PIPLC sensitive (Fig. 2B).
The gBgpi mutant was expressed at the cell surface similarly
to wild-type gB. Surprisingly, gBgpi was not sensitive to
PIPLC cleavage in this assay (Fig. 2C). These results
demonstrate that the gDgpi and gHgpi proteins were
expressed at the cell surface and linked to the plasma
membrane via a gpi tether as predicted.
It was normal to observe a percentage of gDgpi and
gHgpi that was unable to be removed from the cell surface
by PIPLC. Many studies have observed incomplete re-
moval of well-known gpi-linked proteins from the cell
surface by PIPLC treatment (Airas et al., 1997; Beghdadi-
Rais et al., 1993; Caras et al., 1987, 1989; Crise et al.,
1989; Davitz et al., 1986; Diamond et al., 1990; Kemble et
al., 1993; Low, 1989; Low and Kincade, 1985; Skretting et
al., 1999; Wang and Bergelson, 1999; Zhou et al., 1997).
The degree to which any gpi-anchored protein is suscep-
tible to PIPLC depends on the cell line used, potential
modifications of the gpi anchor to render it resistant to
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protein affecting access of PIPLC to the anchor, the
processivity of the PIPLC, and level of protein expressed
(Airas et al., 1997; Diamond et al., 1990; Low, 1989;
Skretting et al., 1999). A major concern was that the
‘‘PIPLC-resistant’’ gDgpi failed to receive a gpi anchor
and then would span the plasma membrane using the
hydrophobic stretch in the DAF gpi-addition sequence.
However, the hydrophobic domain contained in the DAF
gpi-addition sequence is unable to act as a transmembrane
domain for gD, and that sequence is not sufficient to
confer plasma membrane association (Caras et al., 1989).
Proteins with gpi-addition signals that are not processed to
add a gpi anchor are degraded in the ER or are secreted
into the extracellular space and do not have plasma
membrane association (Caras et al., 1989; Field et al.,
1994; Moran et al., 1991). Therefore, the gpi-anchored
protein that remains on the cell surface after PIPLC
incubation is not associated with the plasma membrane
via the hydrophobic sequence in the gpi-addition signal.
Versions of gDgpi nearly identical to the one described
here have been extensively studied and shown to behave
exactly as predicted for a gpi-linked protein (Beghdadi-
Rais et al., 1993; Caras et al., 1987, 1989; Lisanti et al.,
1989, 1990, 1991).
As a further indication of cell-surface expression and
PIPLC sensitivity, CHO-K1 cells transiently expressing the
wild-type or gpi-linked versions of gD, gH, and gB were
incubated with PIPLC, washed, incubated with glycopro-
tein-specific polyclonal or monoclonal antibody followedFig. 3. Cell-surface expression and PIPLC sensitivity of gBgpi, gDgpi, and gHgpi u
expressing wild-type versions of gB, gD, or gH, gpi-linked versions, or control pl
treated with PIPLC (dark line open curves) or mock treated (shaded curves) and th
detected using anti-gD antiserum R7, the anti-gH antibody 52S-43 was used to det
detect cell-surface gB and gBgpi. The experiment was repeated three times and rby secondary FITC-conjugated antibodies, and analyzed
by flow cytometry. Both the wild-type and gpi-linked
versions of gH were co-expressed with gL. Expression
of gDgpi and gHgpi was readily detectable at the cell
surface in the absence of PIPLC treatment (Fig. 3). After
PIPLC treatment, there was a significant reduction in
surface expression of both gDgpi and gHgpi although
the wild-type versions of gD and gH were unaffected by
PIPLC treatment (Fig. 3). Cell-surface gBgpi was again
resistant to cleavage by PIPLC using the flow cytometry
analysis (Fig. 3).
One possible explanation for the lack of PIPLC cleavage
is that the structure of the extracellular domain of gB
blocked PIPLC access to the gpi anchor. To circumvent that
potential problem, we attempted to detect the gpi anchor in a
more direct manner. We labeled cells expressing gBgpi and
gDgpi with 35S-methionine or with 3H-ethanolamine and
immunoprecipitated the labeled cell lysates with specific
antibodies to gB or gD. The gDgpi mutant was analyzed as
a positive control because gDgpi was PIPLC sensitive and
clearly gpi anchored. The gHgpi mutant was not analyzed
because it was PIPLC sensitive and clearly gpi anchored.
The 35S-methionine will label the polypeptide, and the 3H-
ethanolamine will label the gpi anchor. The results in Fig. 4
show that gD, gB, and their corresponding gpi-linked
versions were immunoprecipitated from transfected CHO-
K1 cells labeled with 35S-methionine. The gBgpi and gDgpi
mutants were labeled with the 3H-ethanolamine although the
wild-type versions of the proteins were not (Fig. 4). The
labeling of both gDgpi and gBgpi with 3H-ethanolaminesing flow cytometry analysis. CHO-K1 cells were transfected with plasmids
asmid (pCAGGS, dashed line open curve). Transfected CHO-K1 cells were
en processed for flow cytometry. Cell-surface gD and gDgpi expression was
ect cell-surface expression of gH and gHgpi, and R74 antiserum was used to
esults from a representative experiment are shown.
Fig. 5. Binding of nectin-1 to the surfaces of cells expressing wild-type gD
or gDgpi. (A) CHO-K1 cells were transfected with plasmids expressing gD,
gDgpi, or control plasmid. The cells were incubated with culture media
containing a nectin-1/rabbit IgG Fc fusion protein (nectin-1:Fc), a
biotinylated anti-rabbit IgG, and a streptavidin-conjugated horseradish
peroxidase. Peroxidase activity was measured as an indication of nectin-
1:Fc binding to the cell surface. The experiments were performed three
times and the relative mean values plus standard deviations are shown.
Incubation of the transfected cells with control supernatant yielded
background levels of binding and is not shown. (B) Parallel analysis of
cells transfected in A for cell-surface expression of gD and gDgpi using
anti-gD antiserum R7. The transfected cells were processed for CELISA as
described in Materials and methods.
Fig. 4. Metabolic labeling and immunoprecipitation analysis to determine if the gBgpi mutant contains a gpi anchor. CHO-K1 cells were transfected with
plasmids expressing gD, gDgpi, gB, gBgpi, or control plasmid (pCAGGS). One-half of each transfected population was labeled overnight with 35S-methionine/
cysteine and the other half labeled with 3H-ethanolamine. The cell lysates were immunoprecipitated with either anti-gD antiserum R7 or the anti-gB polyclonal
serum R74 and subjected to SDS-PAGE (10% gel).
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possessed a gpi anchor. Because the immunoprecipitation
results indicate that gBgpi contained a gpi anchor, the
inability of PIPLC to remove gBgpi from the cell surface
suggests that the structure of gBgpi may prevent access of
PIPLC to the gpi anchor.
Interestingly, the level of gB expression appeared to be
greater than that of gBgpi in the immunoprecipitation
experiments (Fig. 4), yet the cell-surface expression of gB
and gBgpi was approximately equivalent in another exper-
iment (Fig. 3). The cytoplasmic tail of gB contains retrieval
sequences that down-regulate expression of gB from the cell
surface (Beitia Ortiz de Zarate et al., 2004; Brideau et al.,
2000) and gB mutants lacking those sequences accumulate
at the cell surface (Beitia Ortiz de Zarate et al., 2004).
Because gBgpi lacks the cytoplasmic tail, there may be an
accumulation of the mutant at the cell surface. Therefore,
although the total levels of gBgpi expressed in cells may be
reduced when compared to gB, cell-surface expression
could be equivalent.
gDgpi binds a secreted form of nectin-1 with wild-type gD
efficiency
The binding of gD to a cell-surface receptor is critical for
fusion (Ligas and Johnson, 1988; Pertel et al., 2001).
Therefore, we tested the ability of the gDgpi mutant to bind
the gD receptor nectin-1. We transfected CHO-K1 cells with
plasmids expressing gD or gDgpi and then incubated the
cells with a secreted form of nectin-1 (nectin-1:Fc). After
the incubation, the live cells were washed and fixed before
the addition of a detection system similar to that used for
CELISA analysis (Materials and Methods). The results
shown in Fig. 5A demonstrate that the nectin-1:Fc protein
bound to cell-surface gD and gDgpi approximately equiv-
alently. The CELISA analysis done in parallel with the
nectin-1:Fc binding experiment demonstrates that there was
approximately equivalent cell-surface expression of gD and
gDgpi (Fig. 5B). Therefore, the removal of the gD trans-membrane domain and cytoplasmic tail and corresponding
addition of a gpi anchor did not interfere with the ability of
gDgpi to bind nectin-1.
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Efficient expression of HSV-1 gH at the surface of the
virion or at the cell surface requires the co-expression of gL
and the formation of a gH-gL heterodimer (Hutchinson et
al., 1992; Roop et al., 1993). Efficient cell-surface expres-
sion of gH and gHgpi was dependent upon gL co-expression
(Fig. 2B), suggesting that gHgpi, like gH, associated with
gL to reach the cell surface. To demonstrate more clearly
that gHgpi formed a complex with gL, we conducted co-
immunoprecipitation and Western blot analysis on cells co-
expressing gHgpi and gL. CHO-K1 cells expressing either
gH and an HA epitope-tagged version of gL or gHgpi and
an HA-tagged version of gL were lysed and immunopreci-
pitated using an anti-gH monoclonal antibody. Western blot
analysis of the immunoprecipitated proteins using an anti-
HA monoclonal antibody clearly demonstrates that gL was
co-immunoprecipitated with gH and gHgpi, indicating that
gHgpi bound gL (Fig. 6).
The gBgpi mutant binds dimer-dependent and
conformation-dependent monoclonal antibodies
The inability of PIPLC to cleave the gpi anchor of the
gBgpi mutant may indicate that the gBgpi mutant was not
folded properly. To address this possibility, we measured
the cell-surface expression of gBgpi in CHO-K1 cells using
well-characterized anti-gB monoclonal antibodies. The
monoclonal antibodies H233, H352, H420, and H1783
bind to epitopes D2a, D3a, Dd5a, and Dd6, respectively,
and the epitopes span the gB extracellular domain (Chapsal
and Pereira, 1988; Pereira et al., 1989; Qadri et al., 1991).
All four monoclonal antibodies recognize conformation-
dependent domains on gB, and H420 and H1783 recognize
gB dimers but not monomers (Chapsal and Pereira, 1988;
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gHgpi and gL, gH, gHgpi, gL, or control cells were lysed and
immunoprecipitated with the anti-gH monoclonal antibody 52S-43. The
immunoprecipitates were subjected to SDS-PAGE and transferred to
nitrocellulose. Western blot analysis was performed using a rat anti-HA
monoclonal antibody and chemiluminescence detection system to detect the
HA epitope-tagged gL.Pereira et al., 1989; Qadri et al., 1991). CHO-K1 cells
expressing gB, gBgpi, or control DNA were subjected to
CELISA analysis with the four conformation-dependent
antibodies as well as the conformation-independent anti-
body H1817 (epitope D1a) (Chapsal and Pereira, 1988;
Pereira et al., 1989; Qadri et al., 1991). Cells expressing
the gBgpi mutant bound all monoclonal antibodies approx-
imately equivalently to wild-type gB with the exception of
H352 and H420 which bound approximately 150% and
50% better, respectively, to gBgpi-expressing cells (Fig. 7).
These results indicate that the gBgpi mutant formed a
dimer and was not grossly misfolded when compared to
wild-type gB. However, the lack of transmembrane and
cytoplasmic domains in the gBgpi mutant rendered epito-
pes in the extracellular domain, D3a and Dd5a, more
accessible to antibody binding when compared to wild-
type gB.
Fusion activity of gpi-linked mutant envelope glycoproteins
To test the ability of the gpi-linked mutants to contribute
to envelope glycoprotein-induced fusion, we performed two
different cell fusion assays. The first was a cell-mixing
assay in which we transfected CHO-K1 cells with a
plasmid expressing T7 RNA polymerase and either plas-
mids expressing gB, gD, gH, and gL, or three of the wild-
type envelope glycoproteins with one of the gpi-linked
versions. We mixed those transfected cells with CHO-K1
cells transfected with a plasmid expressing the gD receptor
nectin-1 and a plasmid containing the E. coli lac z gene
under the control of the T7 promoter. CHO-K1 cells are
normally resistant to HSV-1-induced fusion and must
express a gD receptor to be capable of fusing with HSV-
1 envelope glycoprotein-expressing cells (Pertel et al.,
2001). h-Galactosidase (h-gal) activity will be detected
only when the two transfected cell populations fuse, the
cell contents mix, and the T7 polymerase enters the nucleus
to activate h-gal expression. A similar cell-mixing fusion
assay has been described (Pertel et al., 2001). The second
fusion assay detects cell fusion by observing the formation
of syncytia. Syncytia were formed when B78H1 cells over-
expressing the gD receptor nectin-1 (B78H1-C10 cells)
were transfected with envelope glycoprotein expression
plasmids and monitored microscopically. B78H1 cells are
normally resistant to fusion induced by HSV-1 and require
ectopic expression of a gD receptor to form syncytia. A
similar syncytium assay has been described (Connolly et
al., 2003).
The results of the cell mixing experiments are shown in
Fig. 8. The only gpi-linked version of an envelope
glycoprotein that mediated detectable fusion was gDgpi.
Cells expressing gB, gDgpi, gH, and gL fused nearly as
well as cells expressing gB, gD, gH, and gL (Fig. 8B).
There is a requirement for gD to be linked to the plasma
membrane, however, because a secreted form of gD was
unable to substitute for wild-type gD to mediate cell
Fig. 7. The binding of gBgpi to conformation-dependent and dimer-dependent antibodies. CHO-K1 cells transfected to express gB, gBgpi, or a control plasmid
were incubated separately with five different monoclonal antibodies. The monoclonal antibodies H233, H352, H420, and H1783 are conformation dependent.
Antibodies H420 and H1783 bind only to gB dimers. The H1817 monoclonal antibody detects a linear epitope. The experiments were performed three times
and the mean values plus standard deviations for the combined results are depicted. Within each experiment with a particular antibody, all values were made
relative to the value obtained for the positive control (gB). The actual values for gB expressing cells ranged from 0.12 to 0.36 O.D. 370 nm. The absence of
error bars for mean relative values given is due to standard deviations too small to generate visible error bars.
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experiments with cells expressing gBgpi, gD, gH, and gL
or gB, gD, gHgpi, and gL (Figs. 8A and C, respectively)
despite approximately equivalent cell-surface expression
for gpi-linked mutants and wild-type glycoproteins (Figs.
8A and C).
The gpi-addition sequence in gBgpi was inserted imme-
diately before hydrophobic domain 1 to ensure that gBgpi
would not span the membrane (Fig. 1). However, hydro-
phobic domain 3 is sufficient for stable transmembrane
anchoring whereas hydrophobic domains 1 and 2, either
alone or together, are not capable of conferring stable
membrane association (Rasile et al., 1993). The third
hydrophobic domain may be the only membrane-spanningdomain and the first two hydrophobic domains could
contain sequences important for fusion activity. Thus, we
created an additional gBgpi mutant, gBgpi2, where the gpi-
addition sequence was placed just before the third hydro-
phobic domain. The gBgpi2 mutant contained hydrophobic
domains 1 and 2, was expressed at the surface of the cell,
and bound conformation-dependent antibodies similarly to
wild-type gB (data not shown). Further, similarly to gBgpi,
gBgpi2 was resistant to PIPLC cleavage and did not
function to promote cell fusion (data not shown). The
addition of hydrophobic domains 1 and 2 in the gBgpi2
mutant did not confer fusion activity.
The results for the syncytium formation assay are
depicted in Fig. 9. B78H1-C10 cells were transfected with
Fig. 8. Fusion activity of gpi-linked mutants in a cell-mixing fusion assay. The top graph shows the results of the fusion assay and the bottom graph represents
cell-surface expression of envelope glycoproteins in the fusion assay. The fusion/CELISA experiments were performed at least three times and the mean values
plus standard deviations for the combined results are depicted. Within each experiment, all values were made relative to the value obtained for the positive
control (n1/env+ for the fusion assay and the env+ for the CELISA). (A) CHO-K1 cells were transfected with plasmids expressing gD, gH, gL, and T7
polymerase, including also a plasmid expressing gB (env+), gBgpi (env-gBgpi), or control plasmid (env-gB). Those transfected cells were mixed with CHO-
K1 cells transfected with pG1NTT7h-gal and a plasmid expressing nectin-1 (n1) or CD4 (CD4). Values obtained for the positive control n1/env+ ranged
between 0.225 and 0.447 O.D. 570 nm. Anti-gB monoclonal antibody H1817 was used to measure gB and gBgpi cell-surface expression. The values obtained
for the positive control env+ transfection ranged between 0.098 and 0.129 O.D. 370 nm. (B) CHO-K1 cells were transfected as in A except that a plasmid
expressing gDgpi (env-gDgpi), a secreted gD:Fc fusion protein (env-gD:Fc), or a control plasmid (env-gD) was substituted for wild type gD (env+) in the
transfections. The values obtained for the positive control n1/env+ ranged 0.339–0.447 O.D. 570 nm. The anti-gD antiserum R7 was used in the CELISA
analysis and the values obtained for the positive control env+ transfection ranged 0.222–0.570 O.D. 370 nm. The absence of error bars for relative values given
is due to standard deviations too small to generate a visible error bar. (C) CHO-K1 cells were transfected as in A except that a plasmid expressing gHgpi (env-
gHgpi) or a control plasmid (env-gH) was substituted for wild-type gH (env+) in the transfections. The values obtained for the positive control n1/env+
ranged 0.239–0.447 O.D. 570 nm. The anti-gH monoclonal antibody 52S-43 was used in the CELISA analysis and the values obtained for the positive control
env+ transfection ranged 0.294–0.362 O.D. 370 nm.
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one of the gpi-linked versions substituted. The ability of
each transfected cell population to form syncytia was
examined microscopically at 24, 48, and 72 h. Syncytia
were readily observed at 24 h for the transfections with
plasmids expressing gB, gD, gH, and gL and for the
transfections of plasmids expressing gB, gDgpi, gH, and
gL (Fig. 9). The syncytia were approximately equal in size
and number for the transfections expressing gB, gD, gH,
and gL when compared to those expressing gB, gDgpi, gH,
and gL at 24 h. Upon further incubation, the syncytia
formed by the gB, gD, gH, and gL transfection recruited
more cells, fused together with neighboring syncytia, andincreased greatly in size. Interestingly, the syncytia formed
by the gB, gDgpi, gH, and gL transfection increased in size
over time but did not appear to increase in size similarly to
the wild-type situation. At the 48- and 72-h time points, the
syncytia formed in the transfections with the gDgpi mutant
were clearly not as large as those formed in the trans-
fections with the wild-type glycoproteins (Fig. 9). This
small-syncytia phenotype in transfections with the gDgpi
mutant was not a phenomenon related to the clonal nature
of the B78H1-C10 cells because the phenotype was also
observed in CHO-K1 cells expressing nectin-1, CHO
HveC-1 cells (Geraghty et al., 1998), and an independently
isolated B78H1 cell line expressing nectin-1, B78H1 CJ4E
Fig. 9. Syncytium formation using wild-type envelope glycoproteins and gpi-linked mutants. B78H1-C10 cells were transfected with plasmids expressing gB,
gD, gH, and gL (gB, gD, gH, gL), plasmids expressing gB, gDgpi, gH, and gL (gB, gDgpi, gH, gL), plasmids expressing gB, gH, gL, and control plasmid
pCAGGS (gB, gH, gL), or control plasmid (Control). At 24, 48, or 72 h after transfection, the cells were fixed with methanol and stained with giemsa. Pictures
of the cells were taken under identical conditions. Transfections of plasmids expressing gBgpi, gD, gH, and gL or gB, gD, gHgpi, and gL appeared identical to
the results with the control plasmid and were not included.
N.A. Jones, R.J. Geraghty / Virology 324 (2004) 213–228 221cells (data not shown). The B78H1 CJ4E cells have similar
virus entry characteristics to the B78H1-C10 cells (data not
shown). Transfections including a gBgpi or gHgpi plasmid
and transfections using B78H1 cells that did not express
nectin-1 did not produce syncytia (data not shown). In
conjunction with the results from the cell-mixing assay,
these syncytium formation results demonstrate that the
gDgpi mutant promoted cell fusion when co-expressed
with gB, gH, and gL. The gBgpi and gHgpi mutants were
unable to mediate fusion when co-expressed with gD, gH,
and gL or gB, gD, and gL, respectively. Additionally, the
syncytia formed using the gDgpi mutant were not as large
as those with wild-type gD at time points after 24 h,
indicating a subtle difference in syncytium formation
activity.
A previously published report failed to detect fusion
when a gDgpi mutant was expressed with wild-type gB,
gH, and gL in a cell fusion assay (Browne et al., 2003). The
assay involved expressing the envelope glycoproteins in
293T cells, overlaying with Vero cells, and counting the
resulting syncytia. We performed the 293/Vero fusion assaywith our wild-type envelope glycoprotein expression plas-
mids and the gDgpi mutant. In agreement with the previ-
ously published results, and in contrast with our results in
Figs. 8 and 9, we were unable to detect the formation of
syncytia in the transfections with the gDgpi mutant using
the 293/Vero assay (data not shown). We were able to detect
syncytium formation when all four wild-type envelope
glycoproteins were expressed. The gDgpi mutant was
expressed equivalently to wild-type gD in the 293T cells
(data not shown). Therefore, there was a cell-line depen-
dence for the detection of fusion involving the gDgpi
mutant. One difference among the cell lines in the fusion
assay was the level of nectin-1 expression. In flow cytom-
etry experiments using an anti-nectin-1 monoclonal anti-
body, the mean fluorescence intensity of nectin-1 expression
on the cells used in the syncytium assay in this report
(B78H1-C10) was 35-fold higher than 293T cells and 15-
fold higher than Vero cells (data not shown). Greater nectin-
1 expression likely affords greater sensitivity in the fusion
assay and could explain our ability to detect fusion mediated
by gDgpi in two of the three fusion assays.
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The results presented here indicate that HSV-1 gD does
not require a transmembrane domain or cytoplasmic tail to
mediate cell fusion when co-expressed with gB, gH, and gL.
The gDgpi mutant was tethered to the outer leaflet of the
plasma membrane, and therefore did not span the mem-
brane, yet contributed to fusion activity. Some association
with the plasma membrane was required, however, because
a secreted form of gD lacking a transmembrane domain and
cytoplasmic tail was unable to mediate fusion when
expressed with gB, gH, and gL. The gBgpi and gHgpi
mutants did not promote cell fusion indicating that the
transmembrane domain and cytoplasmic tail were critical
for gB and gH function, which is in agreement with other
studies (Baghian et al., 1993; Diakidi-Kosta et al., 2003; Fan
et al., 2002; Foster et al., 2001; Gage et al., 1993; Harman et
al., 2002).
There are many possible explanations for why the gBgpi
and gHgpi mutants did not function in cell fusion. An
intriguing possibility is that the transmembrane and cyto-
plasmic domains of gB and gH are required to provide an
anchor for interaction of their extracellular domains with the
apposing membrane to form fusion pores and achieve full
fusion. Under that hypothesis, the lack of a membrane-
spanning domain would render gBgpi and gHgpi nonfunc-
tional for fusion. An alternative explanation is that the
mutants did not function because they were improperly
folded. Some gpi-anchored proteins differ in folding from
their wild-type versions (Maillard and Gaudin, 2002; Zhou
et al., 1997), but we do not think the gBgpi or gHgpi
proteins were entirely misfolded. The gBgpi mutant was
recognized by conformation-dependent and dimer-depen-
dent antibodies, suggesting it was not grossly misfolded.
The gHgpi mutant bound a conformation-dependent anti-gH
monoclonal antibody, bound gL, and was transported to the
cell surface similarly to wild type gH; therefore, it is not
obviously misfolded. Analysis of the fusion activity of gH
cytoplasmic tail deletion mutants, however, has identified
amino acids present in the cytoplasmic tail that are critical
for gH to function in fusion (Harman et al., 2002). The lack
of fusion observed with the gHgpi mutant could be due, on
the whole or in part, to the absence of those amino acids.
It was surprising that gBgpi was not cleavable by PIPLC.
Certain cells can modify gpi anchors such that they are not
cleavable by PIPLC (Richier et al., 1992; Walter et al.,
1990; Wong and Low, 1992). It is unlikely that the gpi
anchor for only gBgpi (and not gDgpi and gHgpi) would be
modified by CHO-K1 cells to render it resistant to PIPLC.
To explore that potential problem, we attempted to cleave
the gpi anchor with PIPLD. PIPLD has been used in
instances where the gpi anchor has been modified to be
resistant to PIPLC cleavage (Deeg and Davitz, 1995). We
were unable to remove gBgpi from the cell surface with
PIPLD (data not shown), suggesting that modification of the
gpi anchor to prevent cleavage by PIPLC is not likely.Another possibility is that the structure of gBgpi prevented
access of PIPLC to the gpi anchor. Certain mutants of the
prion protein exhibit altered protein structure such that they
block PIPLC access and subsequent cleavage of their gpi
anchors (Narwa and Harris, 1999). Lastly, gBgpi may stay
associated with the plasma membrane after the gpi anchor is
cleaved and only appear resistant to PIPLC cleavage.
Although the gDgpi mutant clearly promoted cell fusion
when expressed with gB, gH, and gL, there were two subtle
differences in cell fusion between the mutant and wild-type
glycoproteins. First, we were surprised that the syncytia
formed with gDgpi were smaller than those formed with
wild-type gD at 48 and 72 h, especially because syncytia
formed at 24 h were identical in number and size. The
difference in the size of syncytia at the later times may
reflect a difference in the expression pattern of gDgpi vs.
wild-type gD at the surface of a syncytium. Proteins that are
gpi linked often display increased mobility in membranes
compared to proteins with transmembrane domains. The
gDgpi mutant may diffuse throughout the plasma membrane
of a syncytial cell at a rate different from wild-type gD, gB,
and gH/gL, and therefore be improperly localized to pro-
mote fusion. Such an effect may only be seen once syncytia
attain a certain size, hence the initial syncytia are not
affected. We do not believe the difference in syncytium
formation for gDgpi and wild-type gD is simply the result of
less cell-surface expression of gDgpi. We have always
observed approximately equivalent expression at the cell
surface between gpi-linked mutants and wild-type proteins
(Fig. 2). Regardless, our results reveal a difference between
the syncytium formation and cell-mixing assays for cell
fusion. The cell-mixing assay probably involves the fusion
of two or a few cells to generate h-gal activity. The
syncytium formation assay clearly requires many cells
(and even syncytia) to fuse together. The massive cell fusion
required for syncytium formation may involve cytoskeletal
or other elements to a greater extent than necessary in the
fusion of few cells in the cell-mixing assay.
Secondly, the cell fusion assays performed in this report
differed in their abilities to detect fusion involving gDgpi.
The gDgpi mutant promoted cell fusion when expressed
with gB, gH, and gL in two fusion assays where nectin-1
expression was relatively high (cell mixing, Fig. 8, and
syncytium formation, Fig. 9) but no fusion was observed
when gDgpi was expressed with gB, gH, and gL in cells
with relatively low nectin-1 expression (293/Vero, data not
shown). Although there are many potential factors differen-
tially expressed among CHO-K1, B78H1, Vero, and 293
cells, the most relevant difference is likely to be nectin-1
expression. It is unlikely that the observed differences in cell
fusion were due to nectin-1 binding because gD and gDgpi
bound soluble nectin-1 equivalently (Fig. 5). However,
because the CELISA assay used a secreted form of nectin-
1 to measure binding, we cannot rule out the possibility that
binding to a membrane-bound form of nectin-1 could differ
between gD and gDgpi. Alternatively, post-receptor-binding
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more gDgpi/nectin-1 complexes than are required for fusion
with wild-type gD and nectin-1. Under that scenario, cell
fusion might not be observed with gDgpi in situations where
nectin-1 expression is limited. Lastly, the difference in
mobility of gpi-linked proteins when compared to trans-
membrane proteins, as mentioned above, may make cell
fusion less efficient in the relatively low nectin-1 expression
system.
Since the gDgpi mutant functioned in fusion, it is
unlikely that gD performs a role in fusion identical to type
I fusion proteins because gpi-anchored type I fusion proteins
do not mediate complete fusion (Kemble et al., 1994; Tong
and Compans, 2000; Weiss and White, 1993; Zhou et al.,
1997). The receptor binding and membrane fusion functions
found in type I fusion proteins are likely spread among two,
three, or all four of the HSV-1 envelope glycoproteins
required for cell fusion. Our data are consistent with
receptor binding as a role for gD in fusion. The binding
of gD to receptor probably brings the membranes in close
apposition, but gB or gH-gL likely interacts with the
opposite membrane to mediate the lipid mixing and full
fusion. Upon receptor binding, gD may transmit a signal to
gB or gH-gL to adopt a fusion-active conformation and
carry out the fusion process. This signal, however, cannot be
transmitted through the gD transmembrane domain and
cytoplasmic tail because the gDgpi mutant was competent
to promote cell fusion.Materials and methods
Cell lines and antibodies
CHO-K1 cells were provided by P. Spear (Northwestern
University) and were grown in F12 media supplemented
with 7% fetal bovine serum and pen/strep. B78H1-C10 cells
(provided by P. Spear, Northwestern University) were
grown in DMEM supplemented with 7% fetal bovine
serum, pen/strep, and 500Ag/ml G418. The antibody for
nectin-1 was the mouse monoclonal CK6 (Krummenacher
et al., 2000). Antibodies to HSV-1 glycoproteins were
mouse monoclonal antibodies against HSV-1 gB, H233,
H352, H420, and H1783 (Chapsal and Pereira, 1988;
Pereira et al., 1990; Qadri et al., 1991) (purchased from
Rumbaugh-Goodwin Institute for Cancer Research) as well
as H1817 (Chapsal and Pereira, 1988; Pereira et al., 1990;
Qadri et al., 1991) (purchased from Advanced Biotechnol-
ogies Incorporated #13-120-100); R74, a polyclonal anti-
HSV-1 gB rabbit serum (P. Spear, Northwestern University);
R7, a polyclonal rabbit anti-HSV-1 gD serum (G. Cohen and
R. Eisenberg, University of Pennsylvania); and 52S-43, a
mouse monoclonal to HSV-1 gH (P. Spear, Northwestern
University). The rat anti-HA high-affinity antibody was
purchased from Roche. The biotin- and FITC-conjugated
secondary antibodies were a-mouse biotin, a-rabbit biotin,a-mouse FITC, and a-rabbit FITC (Sigma). The anti-rat
conjugated to horseradish peroxidase was purchased from
Roche.
Construction of expression vectors
Wild-type plasmids expressing HSV-1-gB (pPEP98),
HSV-1-gD (pPEP99), HSV-1-gH (pPEP100), and HSV-1-
gL (pPEP101) were provided by P. Pertel (Northwestern
University) and previously described (Pertel et al., 2001).
Other previously described plasmids include the nectin-1
expression plasmid pCJ4 (Geraghty et al., 2000), CD4
expression plasmid pBG53 (Geraghty et al., 2001), T7
RNA polymerase plasmid pT7pol (provided by P. Pertel,
Northwestern University) (Pertel et al., 2001), the plasmid
expressing h-gal under the control of the T7 promoter,
pG1NT7h-gal (provided by E. Berger, National Institutes
of Health) (Nussbaum et al., 1994), and the plasmid
expressing an HA-epitope tagged gL, pMN116 (provided
by P. Spear Northwestern University) (Novotny et al.,
1996).
The gpi mutants were created by amplifying the extra-
cellular domain of the glycoprotein, amplifying the gpi-
addition sequence of DAF, combining the two purified PCR
products, and conducting PCR using the most 5V and 3V
primers to yield the final full-length product. The gBgpi
expression plasmid was constructed by amplifying pPEP98
with the primers HSVB1601 (5VACGAGCTGACCCTG-
TGGAACGAG) and gBgpiC (5VGTCGGCGTGGATGAC-
CGTGTC). The plasmid pDAF-12 (provided by J. White,
University of Virginia) (Kemble et al., 1993) was amplified
with the primers HSVgBgpi (5VGACACGGTCATCCACG-
CCGACCCAAATAAAGGAAGTGGAACC) and DAFC
(5VCCAACCGAAGGAAAGATG). The two PCR products
were gel purified, combined, and amplified with the primers
HSVB1601 and DAFC. The final product was digested with
restriction enzymes BstEII and BglII. This product was
ligated into pPEP98 digested with BstEII and BglII. The
gDgpi expression plasmid was constructed by amplify-
ing pCJ3 (Geraghty et al., 2000) with the primers
CD3prim (Geraghty et al., 2000) and gD1007C1
(5 VGTTGTTCGGGGTGGCCGGGGGATG) . The
plasmid pDAF-12 was amplified using primers gDgpi
(5VCCCCGGCCACCCCGAACAACCCAAATAAAGGA-
CCCCGGCCACCCCGAACAACCCAAATAAAG-
GAAGTGGAACC) and DAFC. The two PCR products
were gel purified, combined, and amplified with primers
CD3prim and DAFC. The resulting product was ligated
into pCAGGS (provided by Y. Kawaoka, University of
Wisconsin, Madison) (Kobasa et al., 1997) digested with
SmaI. The gHgpi expression plasmid was constructed
by amplifying pPEP100 with the primers HSVgH5
(5VATGGGGAATGGTTTATGGTTCGTGG) and gHgpiC
(5VGGGCTGCGTGTCAAAGGCTAG). The plasmid
pDAF-12 was amplified using primers HSVgHgpi
(5VCTAGCCTTTGACACGCAGCCCCCAAATAAAGGA-
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GAAGTGGAACC) and DAFC. The two PCR products
were gel purified, combined, and amplified with primers
HSVgH5 and DAFC. The resulting product was digested
with BstXI and ligated into pPEP100 digested with XhoI,
treated with vent polymerase to blunt the XhoI overhang, and
digested with BstXI. The plasmid pBG37, expressing the
secreted form of nectin-1, nectin-1:Fc, was constructed by
amplifying the nectin-1a cDNA using the primers Prr113
(5VCGGGATCCGAATTCTGTGATATTGACCTCCACC)
and BG1-2a (5VGCTCTAGAATGGCTCGGATGGGGCT-
TGCG). The resulting product was digested with XbaI and
BamHI and ligated into a plasmid containing the rabbit IgG
Fc region, pKZ374 (provided by J. Young, The Salk Insti-
tute), digested with XbaI and BamHI, to form pBG36. The
pBG36 was then digested with XhoI and NotI to remove the
entire nectin-1:Fc fusion protein ORF. The nectin-1:Fc ORF
was ligated into pcDNA3 digested with XhoI and NotI to
create pBG37. To ensure appropriate construction, all newly
created expression plasmids were verified by determining
the DNA sequence (Davis Sequencing, Davis, CA).
Transfections
In each well of a six-well plate, approximately 80%
confluent CHO-K1 or B78H1-C10 cells were incubated
with 1.5 Ag of plasmid DNA and 5 Al of LipofectAMINE
(GibcoBRL), according to the manufacturer’s instructions.
The cells were incubated with the transfection reagents for
6–8 h and the transfection media was replaced with F12 or
DMEM media/20% fetal bovine serum.
CELISA assay
The transfected cells were replated into 96-well dishes
(approximately 4  104 cells per well) at 24 h post
transfection. The next day, the cells were incubated with a
primary antibody in 50 Al of PBS-ABC (phosphate-buffered
saline supplemented with 0.9 mM Ca2+ and 0.5 mM Mg2+)
containing 3% bovine serum albumin (PBS-ABC/3% BSA).
After 30 min at room temperature, the cells were washed
three times with PBS-ABC and fixed with 100 Al of 2%
formaldehyde–0.2% gluteraldehyde for 10 min at room
temperature. The cells were washed three times with PBS-
ABC/3% BSA, and incubated with a biotinylated secondary
antibody in PBS-ABC/3% BSA for 30 min at room tem-
perature. Following the secondary incubation, the cells were
washed four times with PBS and incubated with AMDEX
streptavidin-conjugated horseradish peroxidase (Amersham
Biosciences) at a 1:15000 dilution in 100 Al of PBS-ABC/
3% BSA/0.1% Tween 20 for 30 min at room temperature.
Following the tertiary incubation, the cells were washed
four times with PBS/0.1% Tween 20 and incubated with
3,3V,5,5V-tetramethylbenzidine in phosphate-citrate buffer
according to the manufacturer’s instructions (Sigma). At
various times after the addition of substrate, the plates wereread at 370 nm in a VersaMax microplate reader (Molecular
Devices). The anti-nectin-1 mouse monoclonal CK6 was
used at 1:400 dilution; all anti-gB mouse monoclonals at
1:500; anti-gB R74 at 1:1000; anti-gD R7 at 1:2000; and
anti-gH monoclonal antibody 52S-43 at 1:500. Biotin-con-
jugated anti-mouse and biotin-conjugated anti-rabbit sec-
ondary antibodies were used at a 1:500 dilution. To aid in
quantitation using the CELISA assay, multiple readings of
each sample were taken over time to ensure a linear
relationship of HRP activity over time. Secondly, each assay
was run with a set of six serial dilutions of recombinant
HRP (USB) that was used to form a standard curve to
ensure our conditions yielded readings in a linear range of
HRP activity vs. amount of enzyme.
In the CELISA experiments using PIPLC, the transfected
cells were incubated with 100 Al of Opti-MEM (GibcoBRL)
or Opti-MEM with 0.2 units per ml PIPLC (Molecular
Probes) before primary antibody incubation. After 3 h at
37 jC in a CO2 incubator, the cells were washed three times
with PBS-ABC. The primary anti-glycoprotein antibody,
secondary antibody, tertiary reagent, and substrate were
added as described above.
Nectin-1 binding assay
To produce the nectin-1:Fc protein, CHO-K1 cells were
transfected with pBG37. Because the nectin-1:Fc protein
consists of the rabbit IgG Fc region replacing the trans-
membrane domain and cytoplasmic tail of nectin-1, cells
expressing the hybrid protein secreted nectin-1:Fc into the
culture medium. The cells were incubated in F12 medium
containing 5% low-Ig calf serum, and 48 h later the culture
supernatant was collected. The culture supernatant was
clarified by low-speed centrifugation before use. For the
binding assay, CHO-K1 cells were transfected with plas-
mids expressing gD, gDgpi, or a control plasmid
(pCAGGS). After 24 h, the transfected cells were replated
into 96-well dishes (approximately 4  104 cells per well).
The next day, the cells were incubated with culture super-
natants containing the nectin-1:Fc molecule or with control
supernatants. After 30 min at room temperature, the cells
were washed five times with PBS-ABC, fixed, incubated
with secondary anti-rabbit biotin-conjugated antibody, ter-
tiary reagent, and substrate, and analyzed by spectrometry
as described above in the CELISA section.
Flow cytometry
Two days post transfection, the cells were incubated with 1
ml of Opti-MEM or Opti-MEM with PIPLC at a concentra-
tion of 0.2 units/ml. After 3 h at 37 jC in a CO2 incubator, the
cells were washed three times with PBS. To remove the cells
from the tissue culture dishes, the cells were rocked in a 37 jC
incubator in a solution of PBS/4 mM EDTA. The cells were
washed in FACS buffer (PBS/2% heat-inactivated fetal
bovine serum) and then incubated for 10 min on ice in 100
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again washed in FACS buffer and then incubated for 10 min
on ice in 100 Al of FITC-conjugated secondary antibody
diluted in FACS buffer. The cells were washed in FACS
buffer and stored on ice in a solution of FACS buffer/1.25 Ag/
ml propidium iodide before flow cytometry analysis. The
antibodies used included anti-gB R74 at 1:400, anti-gD R7 at
1:400; and anti-gH 52S-43 at 1:150. Both FITC-conjugated
anti-mouse and FITC-conjugated anti-rabbit secondary anti-
bodies were used at 1:100 dilutions.
Immunoprecipitations
CHO-K1 cells were transfected with plasmids expressing
gD (pPEP99), gDgpi (pgDgpi), gB (pPEP98), gBgpi
(pgBgpi), or control plasmid (pCAGGS). Twenty-four hours
after transfection, the cells were labeled with 200 ACi/ml 35S
Translabel (ICN) or 160 ACi/ml 3H-ethanolamine hydrochlo-
ride (Amersham) for 16 h. The cells were lysed on ice for 10
min in 1 ml of ice-cold lysis buffer containing 1% Triton X-
100, 10 mM Tris–HCl, pH 7, 145 mM NaCl, 5 mM EDTA,
and aprotinin, leupeptin, and pepstatin each at 10 Ag/ml. The
cell lysates were clarified by centrifugation for 10 min at 4 jC
and then precleared with 75 Al of protein A/G (Pierce) for 1
h at 4 jC. At the same time, 75 Al of protein A/Gwas added to
2 Al of rabbit anti-HSV gD serum R7 or 2Al R74 HSV gB
antiserum, in 1 ml of cold PBS and incubated at 4 jC for 1 h.
The precleared lysates were incubated with the antibody-
protein A/G for 1 h at 4 jC. The immune complexes were
collected by centrifugation for 2 min at 4 jC. The complexes
were washed five times with lysis buffer, boiled for 4 min in
SDS-sample buffer containing 5% h-mercaptoethanol, and
separated on a 10% SDS polyacrylamide gel. After electro-
phoresis, the gel was fixed in 30:10:60 methanol/acetone/
water for 15min. The gel was rinsed with water and soaked in
Autofluor (National Diagnostics) for 20 min before being
dried down and exposed to film.
Co-immunoprecipitation/Western blot assay
CHO-K1 cells were transfected with plasmids expressing
gH (pPEP100), gH and gL (pPEP100 and pMN116), gHgpi
(pgHgpi), gHgpi and gL (pgHgpi and pMN116), or control
plasmid (pCAGGS). The cells were lysed on ice and
immunoprecipitated as detailed in the section above. The
antibody used for immunoprecipitation was the 52S-43
monoclonal anti-gH antibody (2 Al of ascites fluid). The
complexes were boiled and run on a 10% SDS polyacryl-
amide gel as described in the section above. The gel was
transferred to nitrocellulose and the blot was blocked in PBS
with 5% dry milk, 2% BSA, and 0.1% Tween 20, and
incubated with a rat high-affinity anti-HA antibody (1:2,500
dilution) in blocking buffer overnight at 4 jC. The blot was
washed six times in PBS with 0.1% Tween 20, incubated
with goat anti-rat IgG conjugated to horseradish peroxidase
(1:1000 dilution) in blocking buffer for 1 h at roomtemperature, washed six times in PBS 0.1% Tween 20,
and subjected to chemiluminescence detection according to
the manufacturers instructions (Pierce).
Cell mixing fusion assay
The assay conditions used were as previously described
(Pertel et al., 2001) with a few modifications. CHO-K1
effector cells were transfected with the plasmids expressing
the HSV-1 fusion glycoproteins (gB, gD, gH, and gL) and
T7 RNA polymerase. Each individual gpi-linked mutant
was substituted singly for its wild-type counterpart. Target
CHO-K1 cells were transfected with the plasmids express-
ing nectin-1 (pCJ4) and h-gal under control of the T7
promoter (pG1NT7h-gal). Twenty-four hours later, effector
and target cells were mixed in a 1:1 ratio and co-cultivated
for 18 h. h-gal activity was quantitated using the substrate
CPRG (0.7 mg/ml in PBS with 0.5% NP40) and spectrom-
etry. To aid in quantitation of this assay, multiple readings of
each sample were taken to ensure a linear relationship of h-
gal activity over time. Secondly, each assay was run with a
set of six serial dilutions of recombinant h-gal (Roche) that
was used to form a standard curve to ensure our conditions
yielded readings in a linear range of h-gal activity vs.
amount of enzyme.
Syncytium formation assay
B78H1-C10 cells were transfected with plasmids
expressing gB (pPEP98), gD (pPEP99), gH (pPEP100),
and gL (pPEP101). The gpi-linked versions of the glyco-
proteins were substituted singly for their wild-type counter-
parts. At 24, 48, and 72 h, the cells were fixed with
methanol and stained with giemsa. The cells were examined
on an Axiovert S100 inverted microscope at the same
magnification and photographs taken using Axiovision 3
software (Zeiss) at the same exposure.Acknowledgments
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